- Home
- CISS vs ADXN Comparison
CISS vs ADXN Comparison
Compare CISS & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- ADXN
- Stock Information
- Founded
- CISS 2022
- ADXN 2002
- Country
- CISS Greece
- ADXN Switzerland
- Employees
- CISS N/A
- ADXN N/A
- Industry
- CISS Marine Transportation
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CISS Consumer Discretionary
- ADXN Health Care
- Exchange
- CISS Nasdaq
- ADXN Nasdaq
- Market Cap
- CISS 2.8M
- ADXN 10.1M
- IPO Year
- CISS N/A
- ADXN N/A
- Fundamental
- Price
- CISS $3.35
- ADXN $8.83
- Analyst Decision
- CISS
- ADXN Strong Buy
- Analyst Count
- CISS 0
- ADXN 1
- Target Price
- CISS N/A
- ADXN $30.00
- AVG Volume (30 Days)
- CISS 125.1K
- ADXN 14.6K
- Earning Date
- CISS 08-21-2025
- ADXN 08-11-2025
- Dividend Yield
- CISS N/A
- ADXN N/A
- EPS Growth
- CISS N/A
- ADXN N/A
- EPS
- CISS N/A
- ADXN 0.10
- Revenue
- CISS $38,174,754.00
- ADXN $278,508.00
- Revenue This Year
- CISS N/A
- ADXN $86.57
- Revenue Next Year
- CISS N/A
- ADXN N/A
- P/E Ratio
- CISS N/A
- ADXN $0.78
- Revenue Growth
- CISS N/A
- ADXN N/A
- 52 Week Low
- CISS $2.85
- ADXN $6.51
- 52 Week High
- CISS $23.25
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- CISS 44.02
- ADXN 49.41
- Support Level
- CISS $3.26
- ADXN $8.78
- Resistance Level
- CISS $3.49
- ADXN $9.89
- Average True Range (ATR)
- CISS 0.23
- ADXN 0.67
- MACD
- CISS -0.00
- ADXN -0.03
- Stochastic Oscillator
- CISS 28.72
- ADXN 43.01
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.